Literature DB >> 8967978

Physicochemical properties correlated with drug resistance and the reversal of drug resistance in Plasmodium falciparum.

P G Bray1, S R Hawley, M Mungthin, S A Ward.   

Abstract

At high molar excess, verapamil can selectively increase the accumulation and cytotoxicity of structurally dissimilar natural product drugs in many multidrug-resistant tumor cell lines. Such concentrations of verapamil are also capable of increasing the accumulation and activity of chloroquine in chloroquine-resistant strains of the human malaria parasite Plasmodium falciparum. Despite such similarities, it is not clear why chloroquine-resistant P. falciparum is often susceptible to closely related compounds such as amodiaquine, whereas cancer cells are cross-resistant to many structurally unrelated drugs. For 13 aminoquinoline and aminoacridine compounds, relative drug resistance was negatively correlated with lipid solubility at physiological pH (r2 = 0.90, p < 0.0001). The ability of verapamil (5 microM) to reverse drug resistance was also negatively correlated with lipid solubility (r2 = 0.88, p < 0.0001). Furthermore, molar refractivity was weakly correlated with relative drug resistance (r2 = 0.46, p < 0.05) and reversal of drug resistance (r2 = 0.52, p < 0.005). Verapamil increases chloroquine accumulation by resistant parasites, a mechanism suggested to account for its selective chemosensitization effect. We show that the initial rate of chloroquine accumulation by resistant parasites is increased by verapamil. This effect of verapamil is abolished when deoxy-glucose is substituted for glucose. Therefore, verapamil produces an energy-dependent increase in the permeability of resistant parasites to chloroquine. For a panel of four chloroquine-resistant and two chloroquine-susceptible isolates, the effect of verapamil on the accumulation of chloroquine and monodesethyl amodiaquine was found to be correlated (r2 = 0.96, p < 0.001). Verapamil chemosensitization was also correlated for the two drugs (r2 = 0.92, p < 0.005), suggesting a common mechanism. In summary, the degree of drug resistance and the extent of verapamil chemosensitization for a particular drug seem to be dependent on general physical features such as lipid solubility and molar refractivity rather than on closely defined structural parameters. These studies provide insight into this important resistance mechanism of malaria parasites and may provide direction for the development of new drugs that are effective against resistant parasites.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8967978

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  18 in total

Review 1.  Therapy of falciparum malaria in sub-saharan Africa: from molecule to policy.

Authors:  Peter Winstanley; Stephen Ward; Robert Snow; Alasdair Breckenridge
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

2.  Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda.

Authors:  Samuel L Nsobya; Christian Dokomajilar; Moses Joloba; Grant Dorsey; Philip J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2007-06-11       Impact factor: 5.191

Review 3.  Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria.

Authors:  Richard T Eastman; David A Fidock
Journal:  Nat Rev Microbiol       Date:  2009-11-02       Impact factor: 60.633

4.  Synthesis and in vitro and in vivo pharmacological evaluation of new 4-aminoquinoline-based compounds.

Authors:  Matshawandile Tukulula; Mathew Njoroge; Efrem T Abay; Grace C Mugumbate; Lubbe Wiesner; Dale Taylor; Liezl Gibhard; Jennifer Norman; Kenneth J Swart; Jiri Gut; Philip J Rosenthal; Samuel Barteau; Judith Streckfuss; Jacques Kameni-Tcheudji; Kelly Chibale
Journal:  ACS Med Chem Lett       Date:  2013-10-01       Impact factor: 4.345

5.  PfCRT and the trans-vacuolar proton electrochemical gradient: regulating the access of chloroquine to ferriprotoporphyrin IX.

Authors:  Patrick G Bray; Mathirut Mungthin; Ian M Hastings; Giancarlo A Biagini; Dauda K Saidu; Viswanathan Lakshmanan; David J Johnson; Ruth H Hughes; Paul A Stocks; Paul M O'Neill; David A Fidock; David C Warhurst; Stephen A Ward
Journal:  Mol Microbiol       Date:  2006-08-31       Impact factor: 3.501

6.  Parallel synthesis and antimalarial screening of a 4-aminoquinoline library.

Authors:  Peter B Madrid; Nathan T Wilson; Joseph L DeRisi; R Kiplin Guy
Journal:  J Comb Chem       Date:  2004 May-Jun

7.  Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations.

Authors:  Amar Bir Singh Sidhu; Dominik Verdier-Pinard; David A Fidock
Journal:  Science       Date:  2002-10-04       Impact factor: 47.728

Review 8.  Hemozoin: oil versus water.

Authors:  John M Pisciotta; David Sullivan
Journal:  Parasitol Int       Date:  2007-10-13       Impact factor: 2.230

Review 9.  Molecular and physiologic basis of quinoline drug resistance in Plasmodium falciparum malaria.

Authors:  Paul D Roepe
Journal:  Future Microbiol       Date:  2009-05       Impact factor: 3.165

10.  Glutathione transport: a new role for PfCRT in chloroquine resistance.

Authors:  Eva-Maria Patzewitz; J Enrique Salcedo-Sora; Eleanor H Wong; Sonal Sethia; Paul A Stocks; Spencer C Maughan; James A H Murray; Sanjeev Krishna; Patrick G Bray; Stephen A Ward; Sylke Müller
Journal:  Antioxid Redox Signal       Date:  2012-12-20       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.